1. Home
  2. RCUS vs NTST Comparison

RCUS vs NTST Comparison

Compare RCUS & NTST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCUS
  • NTST
  • Stock Information
  • Founded
  • RCUS 2015
  • NTST 2019
  • Country
  • RCUS United States
  • NTST United States
  • Employees
  • RCUS N/A
  • NTST N/A
  • Industry
  • RCUS Biotechnology: Pharmaceutical Preparations
  • NTST Real Estate Investment Trusts
  • Sector
  • RCUS Health Care
  • NTST Real Estate
  • Exchange
  • RCUS Nasdaq
  • NTST Nasdaq
  • Market Cap
  • RCUS 1.2B
  • NTST 1.3B
  • IPO Year
  • RCUS 2018
  • NTST 2020
  • Fundamental
  • Price
  • RCUS $12.20
  • NTST $17.96
  • Analyst Decision
  • RCUS Buy
  • NTST Strong Buy
  • Analyst Count
  • RCUS 8
  • NTST 9
  • Target Price
  • RCUS $20.71
  • NTST $19.25
  • AVG Volume (30 Days)
  • RCUS 772.4K
  • NTST 995.6K
  • Earning Date
  • RCUS 11-05-2025
  • NTST 11-03-2025
  • Dividend Yield
  • RCUS N/A
  • NTST 4.82%
  • EPS Growth
  • RCUS N/A
  • NTST N/A
  • EPS
  • RCUS N/A
  • NTST N/A
  • Revenue
  • RCUS $262,000,000.00
  • NTST $179,740,000.00
  • Revenue This Year
  • RCUS N/A
  • NTST $15.57
  • Revenue Next Year
  • RCUS N/A
  • NTST $5.72
  • P/E Ratio
  • RCUS N/A
  • NTST N/A
  • Revenue Growth
  • RCUS 6.07
  • NTST 21.39
  • 52 Week Low
  • RCUS $6.50
  • NTST $13.42
  • 52 Week High
  • RCUS $18.98
  • NTST $19.18
  • Technical
  • Relative Strength Index (RSI)
  • RCUS 75.43
  • NTST 44.08
  • Support Level
  • RCUS $10.40
  • NTST $17.53
  • Resistance Level
  • RCUS $11.84
  • NTST $18.60
  • Average True Range (ATR)
  • RCUS 0.54
  • NTST 0.33
  • MACD
  • RCUS 0.16
  • NTST -0.14
  • Stochastic Oscillator
  • RCUS 98.35
  • NTST 26.06

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

About NTST NetSTREIT Corp.

Netstreit Corp is an internally managed real estate investment trust. The company acquires, owns, and manages single-tenant, retail commercial real estate subject to long-term net leases with high-credit quality tenants across the United States. It focuses on tenants in industries where a physical location is critical to the generation of sales and profits, with a focus on necessity goods and essential services in the retail sector, including home improvement, auto parts, drug stores and pharmacies, general retail, grocers, convenience stores, discount stores, and quick-service restaurants. Majorily operates in U.S. States and Other counties, and derives maximum of revenue from USA.

Share on Social Networks: